Clinical Trials Logo

Retinal Perforations clinical trials

View clinical trials related to Retinal Perforations.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05494229 Terminated - Ophthalmopathy Clinical Trials

Autologous Blood for Full-thickness Macular Hole

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Autologous blood for primary and recurrent holes

NCT ID: NCT05191628 Terminated - Retinal Detachment Clinical Trials

Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

Start date: June 10, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this open, multicenter trial is to assess the impact of the use of an amniotic membrane graft on the closure of macular hole-associated retinal detachment in patients with failed previous macular surgery.

NCT ID: NCT02295943 Terminated - Macular Hole Clinical Trials

Objective Evaluation of Postoperative Positioning in Macular Hole Surgery

Start date: November 2014
Phase: N/A
Study type: Interventional

The macular hole formation takes place in the centre of the retina. A closure of the macular hole is believed to take place if the central retinal area is kept dry in the postoperative period. Therefore the eye is filled with a gas mix and the patients are urged to avoid the supine position in the first postoperative days. The investigators have developed a positioning measuring device which can measure the extent of supine positioning time. Patients are to carry the positioning measuring device during the first postoperative 24 hours. Hereby the investigators search new knowledge concerning patients compliance and its relation to macular hole closure.

NCT ID: NCT01820520 Terminated - Epiretinal Membrane Clinical Trials

Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

Start date: January 2013
Phase: Phase 3
Study type: Interventional

Study designed to evaluate the safety and efficacy of double staining with brilliant blue G 0.025% as an adjuvant to macular surgery. Patients undergoing surgery for macular hole or epiretinal membrane will be included. Safety will be evaluated by optic coherence tomography, pattern reversal electroretinogram and multifocal electroretinogram.